Skip Navigation

Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more

Chronic Lymphocytic Leukemia Clinical Trials and Research

  • New Patient Appointments
    877-442-3324

    Make Appointment Online
    Dana-Farber/Brigham and Women's Cencer Center logo
    US News adult badge - smaller
  • Clinical Trials Questions?

    877-DF-TRIAL
    (877-338-7425)

     

  • Matthew Davids, MD, MMSc, on Advances in CLL Treatment
    Matthew Davids, MD, MMSc, of Dana-Farber’s Center for Chronic Lymphocytic Leukemia, shares updates on advances in treating newly-diagnosed and relapsed CLL. New approaches include ibrutinib + FCR for younger, newly-diagnosed patients and a combination of rituximab and venetoclax for relapsed patients.

  • View Video Updates on Lymphoma and CLL Trial Research

    See and hear Dana-Farber faculty in informative videos, as they share updates and next steps for their lymphoma and CLL clinical trial research.